Knowledge Center

Webinar / Oct 04, 2023

Webinar - High performance solutions for DPI delivery: new formulation and device platforms

Authors:
  • Susana Saldanha
  • Sofia Silva
Source:
Webinar

October, 2023

11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

Registrations to the webinar are subject to approval.

Join our Webinar Series: High performance solutions for DPI delivery: new formulation and device platforms to be hold on October 4th 2023

Ìý

Featured ËÄÉ«AV experts in this webinar
Webinar_Inhalation_Sunriser_Speaker Susana Saldanha | ËÄÉ«AV

Ìý

Webinar_Inhalation_Sunriser_Speaker Sofia Silva | ËÄÉ«AV

Ìý

Susana Saldanha, M.Sc.
R&D Manager, Inhalation and Advanced Drug Delivery
Sofia Silva, M.Sc.
R&D Manager, Analytical Development

Ìý

This webinar will address the most relevant solutions for dry powder inhaler (DPI) development covering both formulation and device development, as well as process optimization and analytical characterization, under an integrated development approach.Ìý

DPIs are the dosage form of choice for delivering high doses of inhaled drugs and achieving maximum delivery efficiency to patients. This presentation will focus on new formulation platforms, aiming to address the pharmacokinetics requirements of the target drug and indication, coupled with a new high performance, high-dose device platform, theÌýSunriser® DPI.Ìý

This integrated approach is designed to maximize drug delivery efficiency while maintaining safety, and is able to address a diversified array of diseases.

Ìý

Key Learning Objectives:

  • Gain insights on novel formulation development strategies for DPIs, to be able to improve drug delivery efficiency even with high drug loads;
  • Understand the potential of wet milling and dry milling capabilities for boosting the fine particle dose of DPI formulations;
  • Discover analytical characterization techniques, for differentiated formulations, to further understand product properties that impact drug delivery and aerodynamic performance;
  • Understand features associated with a novel high efficiency device platform, the Sunriser® capsule-based Dry Powder Inhaler;
  • Network with industry peers and experts during the live Q&A session.

Who Should Attend:

  • Pharmaceutical researchers and scientists
  • CMC experts on inhalation drug delivery
  • Business development, portfolio management and technology licensing experts
  • Inhalation product development professionals
  • Respiratory therapeutics specialists
    Ìý

Ìý